Zaremba Rabourn Amy bought IRD
January 22, 2026 · Form 4 insider transaction
Zaremba Rabourn Amy bought 86,500 shares of Opus Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
86,500
Price
$0.00
Total value
N/A
InsiderZaremba Rabourn Amy
RoleOfficer
CompanyOpus Genetics, Inc. (IRD)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 22, 2026
Filing dateJanuary 26, 2026
Shares owned after193,128
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.